Showing results (1-10 of 28) with videos related to
Sort By:
Pageof 3
Vaccine|April 2, 2008
Strain-dependent effects of probiotic lactobacilli on EAE autoimmunityCatharina B M Maassen, Eric ClaassenScientific Reports|February 3, 2018
The mechanistic link between health and gut microbiota diversityOlaf F A Larsen, Eric ClaassenVaccine|December 29, 2016
Vector-based genetically modified vaccines: Exploiting Jenner's legacyBahar Ramezanpour, Ingrid Haan, Ab Osterhaus, et al.Critical Reviews in Immunology|May 19, 2018
Functions of CD40 and Its Ligand, gp39 (CD40L)Jon D Laman, Eric Claassen, Randolph J NoelleTrials|July 19, 2019
Probiotics in pregnancy: protocol of a double-blind randomized controlled pilot trial for pregnant women with depression and anxiety (PIP pilot trial)Pamela D Browne, Antoinette Bolte, Eric Claassen, et al.Plos One|December 21, 2013
Food-pharma convergence in medical nutrition- best of both worlds?Tamar C Weenen, Bahar Ramezanpour, Esther S Pronker, et al.Frontiers in Public Health|May 7, 2021
Barriers Influencing Vaccine Development Timelines, Identification, Causal Analysis, and Prioritization of Key Barriers by KOLs in General and Covid-19 Vaccine R&DMarga Janse, Thomas Brouwers, Eric Claassen, et al.Microbial Biotechnology|May 28, 2016
Lactobacillus plantarum WCFS1 and its host interaction: a dozen years after the genomeMaurits van den Nieuwboer, Saskia van Hemert, Eric Claassen, et al.Tropical Medicine & International Health : TM & IH|December 25, 2019
Quantity vs. quality: an assessment of the current pipeline for rabiesAnne M G Neevel, Eduardo Urias, Eric Claassen, et al.Bulletin of the World Health Organization|October 8, 2005
Managing severe acute respiratory syndrome (SARS) intellectual property rights: the possible role of patent poolingJames H M Simon, Eric Claassen, Carmen E Correa, et al.Pageof 3